Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 87.93% vs 273.33% in Jun 2026
Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 6.52% vs 968.79% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 3.77% vs 2,972.46% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is -23.26% vs 65.38% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
Compare Quarterly Results Of Shukra Pharma. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 87.93% vs 273.33% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 651.70% vs 5.76% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 6.52% vs 968.79% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 572.69% vs 340.74% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 3.77% vs 2,972.46% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 5,338.10% vs -162.69% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -23.26% vs 65.38% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 13.79% vs 163.64% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025